Delisting risk
Jaguar Health (JAGX)
Develops and supplies crofelemer treatments for intestinal failure and diarrhea in people and animals.
$0.7398
At close+0.01 (+1.20%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$40.95
Revenue estimate
$4.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Aug '25Nov '25Nov '25Mar '26Apr '26May '26Aug '26Nov '26
Reported−$10.26−$2.20−$6.28−$13.60−$3.14−$13.60−$15.70Pending
Estimate−$7.13−$1.78−$5.08−$71.40−$1.49−$71.40−$52.15−$40.95
Surprise−43.9%−23.6%−23.6%+81.0%−110.6%+81.0%+69.9%—
RevenueReportedEstimate
Aug '25Nov '25Nov '25Mar '26Apr '26May '26Aug '26Nov '26
Reported$3.0M$3.1M$3.1M$2.0M$3.2M$20.3M$1.2MPending
Estimate$3.3M$3.7M$3.7M$3.7M$4.2M$3.7M$4.2M$4.9M
Surprise−8.9%−17.3%−17.3%−44.8%−23.2%+452.4%−71.1%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$40.95 | — | — |
| Aug 2026 | −$52.15 | −$15.70 | +69.9% |
| May 2026 | −$71.40 | −$13.60 | +81.0% |
| Apr 2026 | −$1.49 | −$3.14 | −110.6% |
| Mar 2026 | −$71.40 | −$13.60 | +81.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$40.95 | — | — | $4.9M | — | — | — |
| Aug 19, 2026 | −$52.15 | −$15.70 | +69.9% | $4.2M | $1.2M | −71.1% | −5.5% |
| May 20, 2026 | −$71.40 | −$13.60 | +81.0% | $3.7M | $20.3M | +452.4% | −5.5% |
| Apr 7, 2026 | −$1.49 | −$3.14 | −110.6% | $4.2M | $3.2M | −23.2% | −2.5% |
| Mar 30, 2026 | −$71.40 | −$13.60 | +81.0% | $3.7M | $2.0M | −44.8% | +11.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Nov 12, 2025 | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Mar 24, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 22, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 11, 2022 | |||||||
| Nov 17, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Apr 3, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 21, 2019 | |||||||
| Apr 10, 2019 | |||||||
| Nov 19, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 9, 2018 | |||||||
| Nov 20, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 10, 2016 | |||||||